Jenburkt Pharmaceuticals Live BSE/NSE | Jenburkt Pharmaceuticals Fundamenta data | Jenburkt Pharmaceuticals Balance sheet | Jenburkt Pharmaceuticals Quarterly Results | Jenburkt Pharmaceuticals Profit & Loss | Jenburkt Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

188.62
11.84
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

134.37
1.97%
2.15

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.64
4.90
1.21

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.84
3.70
-3.66

PAT CAGR (%)

10 Years
5 Years
3 Years

9.46
6.64
-4.75

P:E (Median)

8 Years
5 Years
3 Years

14.79
15.42
12.16

P:BV (Average)

8 Years
5 Years
3 Years

2.11
2.11
2.11

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.15
7.95
7.01

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 30.49 34.18 -10.80% 17.43 20.84 -16.36% 30.28 35.13 -13.81% 33.59 32.28 4.06%
Expenses 23.31 26.76 -12.89% 16.80 21.46 -21.71% 23.98 26.22 -8.54% 26.95 25.91 4.01%
EBITDA 7.17 7.42 -3.37% 0.63 -0.62 - 6.29 8.91 -29.41% 6.65 6.37 4.40%
EBIDTM 23.52% 21.72% 3.60% -2.98% 20.78% 25.36% 19.78% 19.73%
Other Income 1.02 0.86 18.60% 0.98 1.24 -20.97% 1.29 0.93 38.71% 0.83 0.67 23.88%
Interest 0.12 0.19 -36.84% 0.11 0.07 57.14% 0.12 0.10 20.00% 0.14 0.11 27.27%
Depreciation 0.51 0.54 -5.56% 0.49 0.53 -7.55% 0.57 0.35 62.86% 0.66 0.35 88.57%
PBT 7.56 7.55 0.13% 1.00 0.02 4,900.00% 6.89 9.39 -26.62% 6.67 6.58 1.37%
Tax 1.89 2.00 -5.50% -0.01 -0.04 - 2.27 2.50 -9.20% 2.03 2.11 -3.79%
PAT 5.67 5.55 2.16% 1.01 0.06 1,583.33% 4.62 6.89 -32.95% 4.64 4.46 4.04%
PATM 18.60% 16.25% 5.78% 0.30% 15.25% 19.63% 13.81% 13.82%
EPS 12.33 12.07 2.15% 2.19 0.13 1,584.62% 10.04 14.99 -33.02% 10.08 9.70 3.92%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 111.79 118.89 122.64 114.67 103.31 93.59 85.21 76.22 69.34 59.82 56.92 Net Sales Growth -8.69% -3.06% 6.95% 11.00% 10.39% 9.83% 11.79% 9.92% 15.91% 5.09% Cost Of Goods Sold 30.12 30.06 33.13 31.18 27.84 25.47 23.22 23.71 20.92 18.01 18.50 Gross Profit 81.67 88.83 89.52 83.49 75.47 68.11 62.00 52.52 48.41 41.80 38.42 GP Margin 73.05% 74.72% 72.99% 72.81% 73.05% 72.77% 72.76% 68.91% 69.82% 69.88% 67.50% Total Expenditure 91.04 99.15 97.72 90.89 83.59 77.13 69.96 64.71 59.23 50.35 46.73 Power & Fuel Cost - 0.59 0.59 0.61 0.53 0.57 0.52 0.43 0.39 0.37 0.33 % Of Sales - 0.50% 0.48% 0.53% 0.51% 0.61% 0.61% 0.56% 0.56% 0.62% 0.58% Employee Cost - 36.51 31.20 27.69 25.21 21.49 18.99 16.97 15.81 12.69 11.39 % Of Sales - 30.71% 25.44% 24.15% 24.40% 22.96% 22.29% 22.26% 22.80% 21.21% 20.01% Manufacturing Exp. - 4.45 4.76 4.05 3.92 4.22 4.64 3.48 3.88 3.51 3.43 % Of Sales - 3.74% 3.88% 3.53% 3.79% 4.51% 5.45% 4.57% 5.60% 5.87% 6.03% General & Admin Exp. - 8.27 10.48 10.36 9.78 8.77 8.88 6.67 5.91 4.48 4.02 % Of Sales - 6.96% 8.55% 9.03% 9.47% 9.37% 10.42% 8.75% 8.52% 7.49% 7.06% Selling & Distn. Exp. - 18.72 17.21 16.55 16.00 16.61 13.72 13.46 12.31 11.29 9.05 % Of Sales - 15.75% 14.03% 14.43% 15.49% 17.75% 16.10% 17.66% 17.75% 18.87% 15.90% Miscellaneous Exp. - 0.54 0.35 0.45 0.31 0.00 0.00 0.00 0.00 0.00 9.05 % Of Sales - 0.45% 0.29% 0.39% 0.30% 0% 0% 0% 0% 0% 0.04% EBITDA 20.74 19.74 24.92 23.78 19.72 16.46 15.25 11.51 10.11 9.47 10.19 EBITDA Margin 18.55% 16.60% 20.32% 20.74% 19.09% 17.59% 17.90% 15.10% 14.58% 15.83% 17.90% Other Income 4.12 4.22 3.45 3.39 2.96 2.73 2.07 1.61 1.12 0.82 0.43 Interest 0.49 0.53 0.39 0.41 0.41 0.38 0.36 1.26 0.94 0.63 0.55 Depreciation 2.23 2.30 1.35 1.50 1.79 1.99 2.66 1.55 1.48 1.22 0.98 PBT 22.12 21.14 26.63 25.27 20.48 16.82 14.31 10.31 8.81 8.44 9.09 Tax 6.18 6.27 6.84 8.06 6.97 6.05 4.69 2.82 2.61 2.53 3.07 Tax Rate 27.94% 29.66% 25.69% 31.90% 34.03% 35.95% 32.71% 27.30% 29.59% 29.69% 33.77% PAT 15.94 14.87 19.80 17.21 13.51 10.78 9.65 7.51 6.22 6.00 6.02 PAT before Minority Interest 15.94 14.87 19.80 17.21 13.51 10.78 9.65 7.51 6.22 6.00 6.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.26% 12.51% 16.14% 15.01% 13.08% 11.52% 11.32% 9.85% 8.97% 10.03% 10.58% PAT Growth -6.01% -24.90% 15.05% 27.39% 25.32% 11.71% 28.50% 20.74% 3.67% -0.33% Unadjusted EPS 34.65 32.33 43.04 37.41 29.37 23.43 20.98 16.33 13.52 13.04 13.09

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

111.79

118.89

122.64

114.67

103.31

93.59

85.21

76.22

69.34

59.82

56.92

Net Sales Growth

-8.69%

-3.06%

6.95%

11.00%

10.39%

9.83%

11.79%

9.92%

15.91%

5.09%

Cost Of Goods Sold

30.12

30.06

33.13

31.18

27.84

25.47

23.22

23.71

20.92

18.01

18.50

Gross Profit

81.67

88.83

89.52

83.49

75.47

68.11

62.00

52.52

48.41

41.80

38.42

GP Margin

73.05%

74.72%

72.99%

72.81%

73.05%

72.77%

72.76%

68.91%

69.82%

69.88%

67.50%

Total Expenditure

91.04

99.15

97.72

90.89

83.59

77.13

69.96

64.71

59.23

50.35

46.73

Power & Fuel Cost

0.59

0.61

0.53

0.57

0.52

0.43

0.39

0.37

0.33

% Of Sales

0.50%

0.48%

0.53%

0.51%

0.61%

0.56%

0.62%

0.58%

Employee Cost

36.51

31.20

27.69

25.21

21.49

18.99

16.97

15.81

12.69

11.39

% Of Sales

30.71%

25.44%

24.15%

24.40%

22.96%

22.29%

22.26%

22.80%

21.21%

20.01%

Manufacturing Exp.

4.45

4.76

4.05

3.92

4.22

4.64

3.48

3.88

3.51

3.43

% Of Sales

3.74%

3.88%

3.53%

3.79%

4.51%

5.45%

4.57%

5.60%

5.87%

6.03%

General & Admin Exp.

8.27

10.48

10.36

9.78

8.77

8.88

6.67

5.91

4.48

4.02

% Of Sales

6.96%

8.55%

9.03%

9.47%

9.37%

10.42%

8.75%

8.52%

7.49%

7.06%

Selling & Distn. Exp.

18.72

17.21

16.55

16.00

16.61

13.72

13.46

12.31

11.29

9.05

% Of Sales

15.75%

14.03%

14.43%

15.49%

17.75%

16.10%

17.66%

17.75%

18.87%

15.90%

Miscellaneous Exp.

0.54

0.35

0.45

0.31

0.00

9.05

% Of Sales

0.45%

0.29%

0.39%

0.30%

0.04%

EBITDA

20.74

19.74

24.92

23.78

19.72

16.46

15.25

11.51

10.11

9.47

10.19

EBITDA Margin

18.55%

16.60%

20.32%

20.74%

19.09%

17.59%

17.90%

15.10%

14.58%

15.83%

17.90%

Other Income

4.12

4.22

3.45

3.39

2.96

2.73

2.07

1.61

1.12

0.82

0.43

Interest

0.49

0.53

0.39

0.41

0.38

0.36

1.26

0.94

0.63

0.55

Depreciation

2.23

2.30

1.35

1.50

1.79

1.99

2.66

1.55

1.48

1.22

0.98

PBT

22.12

21.14

26.63

25.27

20.48

16.82

14.31

10.31

8.81

8.44

9.09

Tax

6.18

6.27

6.84

8.06

6.97

6.05

4.69

2.82

2.61

2.53

3.07

Tax Rate

27.94%

29.66%

25.69%

31.90%

34.03%

35.95%

32.71%

27.30%

29.59%

29.69%

33.77%

PAT

15.94

14.87

19.80

17.21

13.51

10.78

9.65

7.51

6.22

6.00

6.02

PAT before Minority Interest

15.94

14.87

19.80

17.21

13.51

10.78

9.65

7.51

6.22

6.00

6.02

Minority Interest

0.00

PAT Margin

14.26%

12.51%

16.14%

15.01%

13.08%

11.52%

11.32%

9.85%

8.97%

10.03%

10.58%

PAT Growth

-6.01%

-24.90%

15.05%

27.39%

25.32%

11.71%

28.50%

20.74%

3.67%

-0.33%

Unadjusted EPS

34.65

32.33

43.04

37.41

29.37

23.43

20.98

16.33

13.52

13.04

13.09

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 80.00 77.47 61.26 54.44 40.19 33.44 27.31 22.65 18.71 14.56 Share Capital 4.59 4.59 4.59 4.65 4.65 4.65 4.65 4.65 4.65 4.65 Total Reserves 75.41 72.88 56.67 49.79 35.54 28.79 22.66 18.00 14.06 9.91 Non-Current Liabilities 0.24 -0.37 3.14 3.67 3.76 3.46 3.81 8.80 8.04 9.26 Secured Loans 0.00 0.00 0.24 0.24 0.25 0.01 0.04 0.02 0.07 0.13 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.15 4.39 5.61 Current Liabilities 24.15 25.44 13.15 18.30 14.08 23.95 12.89 17.50 13.58 12.01 Trade Payables 5.23 6.55 4.12 6.02 3.30 3.82 4.10 3.06 2.28 4.51 Other Current Liabilities 12.79 10.79 8.67 5.45 4.67 4.80 3.95 4.81 4.43 3.33 Short Term Borrowings 3.44 7.47 0.01 6.13 5.17 6.61 1.98 4.55 2.23 2.05 Short Term Provisions 2.70 0.63 0.36 0.70 0.93 8.72 2.86 5.07 4.64 2.13 Total Liabilities 104.39 102.54 77.55 76.41 58.03 60.85 44.01 48.95 40.33 35.83 Net Block 11.73 9.59 9.57 10.63 12.11 11.60 13.57 14.23 13.12 10.27 Gross Block 31.31 26.89 25.69 25.45 25.54 23.49 24.20 23.37 20.88 17.06 Accumulated Depreciation 19.58 17.30 16.12 14.83 13.44 11.88 10.63 9.15 7.76 6.79 Non Current Assets 14.77 12.79 11.55 12.52 12.72 11.92 14.22 14.54 13.89 11.58 Capital Work in Progress 0.12 0.99 0.00 0.00 0.00 0.00 0.00 0.00 0.24 0.52 Non Current Investment 2.50 1.86 1.63 1.39 0.61 0.31 0.31 0.31 0.53 0.79 Long Term Loans & Adv. 0.29 0.17 0.10 0.26 0.00 0.00 0.33 0.00 0.00 0.00 Other Non Current Assets 0.13 0.18 0.25 0.25 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 89.63 89.75 66.01 63.89 45.31 48.94 29.79 34.41 26.44 24.25 Current Investments 1.57 3.52 3.79 0.55 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 10.90 9.83 6.80 10.75 8.24 7.58 6.50 7.72 6.28 5.80 Sundry Debtors 17.83 22.89 12.54 9.07 5.78 7.38 5.48 6.02 3.68 4.76 Cash & Bank 57.69 51.70 41.11 42.08 29.64 27.51 16.75 11.41 7.93 5.51 Other Current Assets 1.63 0.79 0.80 0.63 1.66 6.47 1.05 9.27 8.54 8.18 Short Term Loans & Adv. 0.78 1.02 0.97 0.81 0.53 0.49 0.30 0.43 0.38 0.45 Net Current Assets 65.48 64.31 52.85 45.59 31.23 24.98 16.90 16.91 12.86 12.24 Total Assets 104.40 102.54 77.56 76.41 58.03 60.86 44.01 48.95 40.33 35.83

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

80.00

77.47

61.26

54.44

40.19

33.44

27.31

22.65

18.71

14.56

Share Capital

4.59

4.65

Total Reserves

75.41

72.88

56.67

49.79

35.54

28.79

22.66

18.00

14.06

9.91

Non-Current Liabilities

0.24

-0.37

3.14

3.67

3.76

3.46

3.81

8.80

8.04

9.26

Secured Loans

0.00

0.24

0.25

0.01

0.04

0.02

0.07

0.13

Unsecured Loans

0.00

Long Term Provisions

0.00

5.15

4.39

5.61

Current Liabilities

24.15

25.44

13.15

18.30

14.08

23.95

12.89

17.50

13.58

12.01

Trade Payables

5.23

6.55

4.12

6.02

3.30

3.82

4.10

3.06

2.28

4.51

Other Current Liabilities

12.79

10.79

8.67

5.45

4.67

4.80

3.95

4.81

4.43

3.33

Short Term Borrowings

3.44

7.47

0.01

6.13

5.17

6.61

1.98

4.55

2.23

2.05

Short Term Provisions

2.70

0.63

0.36

0.70

0.93

8.72

2.86

5.07

4.64

2.13

Total Liabilities

104.39

102.54

77.55

76.41

58.03

60.85

44.01

48.95

40.33

35.83

Net Block

11.73

9.59

9.57

10.63

12.11

11.60

13.57

14.23

13.12

10.27

Gross Block

31.31

26.89

25.69

25.45

25.54

23.49

24.20

23.37

20.88

17.06

Accumulated Depreciation

19.58

17.30

16.12

14.83

13.44

11.88

10.63

9.15

7.76

6.79

Non Current Assets

14.77

12.79

11.55

12.52

12.72

11.92

14.22

14.54

13.89

11.58

Capital Work in Progress

0.12

0.99

0.00

0.24

0.52

Non Current Investment

2.50

1.86

1.63

1.39

0.61

0.31

0.53

0.79

Long Term Loans & Adv.

0.29

0.17

0.10

0.26

0.00

0.33

0.00

Other Non Current Assets

0.13

0.18

0.25

0.00

Current Assets

89.63

89.75

66.01

63.89

45.31

48.94

29.79

34.41

26.44

24.25

Current Investments

1.57

3.52

3.79

0.55

0.00

Inventories

10.90

9.83

6.80

10.75

8.24

7.58

6.50

7.72

6.28

5.80

Sundry Debtors

17.83

22.89

12.54

9.07

5.78

7.38

5.48

6.02

3.68

4.76

Cash & Bank

57.69

51.70

41.11

42.08

29.64

27.51

16.75

11.41

7.93

5.51

Other Current Assets

1.63

0.79

0.80

0.63

1.66

6.47

1.05

9.27

8.54

8.18

Short Term Loans & Adv.

0.78

1.02

0.97

0.81

0.53

0.49

0.30

0.43

0.38

0.45

Net Current Assets

65.48

64.31

52.85

45.59

31.23

24.98

16.90

16.91

12.86

12.24

Total Assets

104.40

102.54

77.56

76.41

58.03

60.86

44.01

48.95

40.33

35.83

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 15.02 12.99 16.18 9.95 7.82 8.69 11.43 4.54 6.92 7.33 PBT 21.14 26.63 25.27 20.48 16.83 14.34 10.33 8.82 8.52 9.09 Adjustment -1.22 -1.65 -1.67 -0.74 -0.50 0.98 1.49 1.38 1.07 1.20 Changes in Working Capital 0.57 -4.90 0.97 -3.01 -2.76 -1.95 2.37 -2.21 0.25 0.46 Cash after chg. in Working capital 20.48 20.08 24.57 16.72 13.57 13.37 14.19 7.99 9.84 10.75 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.94 -0.63 -0.52 Tax Paid -5.46 -7.10 -8.39 -6.77 -5.75 -4.79 -2.83 -2.57 -2.42 -2.90 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.11 0.08 0.06 0.14 0.00 Cash From Investing Activity -2.88 -10.53 1.00 -9.77 -0.27 1.24 0.45 -1.15 -2.84 -3.22 Net Fixed Assets -3.55 -2.19 -0.24 0.09 -2.05 0.71 -0.83 -2.25 -3.54 -3.21 Net Investments 1.31 0.04 -3.48 -1.33 -0.30 0.00 0.00 0.22 0.26 -0.22 Others -0.64 -8.38 4.72 -8.53 2.08 0.53 1.28 0.88 0.44 0.21 Cash from Financing Activity -10.83 -2.42 -17.98 0.68 -5.42 0.83 -6.54 0.08 -1.66 -2.19 Net Cash Inflow / Outflow 1.31 0.04 -0.80 0.86 2.13 10.76 5.34 3.48 2.42 1.92 Opening Cash & Equivalents 1.23 1.18 1.99 1.13 27.51 16.75 11.41 7.93 5.51 3.59 Closing Cash & Equivalent 2.53 1.23 1.18 1.99 29.64 27.51 16.75 11.41 7.93 5.51

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

15.02

12.99

16.18

9.95

7.82

8.69

11.43

4.54

6.92

7.33

PBT

21.14

26.63

25.27

20.48

16.83

14.34

10.33

8.82

8.52

9.09

Adjustment

-1.22

-1.65

-1.67

-0.74

-0.50

0.98

1.49

1.38

1.07

1.20

Changes in Working Capital

0.57

-4.90

0.97

-3.01

-2.76

-1.95

2.37

-2.21

0.25

0.46

Cash after chg. in Working capital

20.48

20.08

24.57

16.72

13.57

13.37

14.19

7.99

9.84

10.75

Interest Paid

0.00

-0.94

-0.63

-0.52

Tax Paid

-5.46

-7.10

-8.39

-6.77

-5.75

-4.79

-2.83

-2.57

-2.42

-2.90

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

0.11

0.08

0.06

0.14

0.00

Cash From Investing Activity

-2.88

-10.53

1.00

-9.77

-0.27

1.24

0.45

-1.15

-2.84

-3.22

Net Fixed Assets

-3.55

-2.19

-0.24

0.09

-2.05

0.71

-0.83

-2.25

-3.54

-3.21

Net Investments

1.31

0.04

-3.48

-1.33

-0.30

0.00

0.22

0.26

-0.22

Others

-0.64

-8.38

4.72

-8.53

2.08

0.53

1.28

0.88

0.44

0.21

Cash from Financing Activity

-10.83

-2.42

-17.98

0.68

-5.42

0.83

-6.54

0.08

-1.66

-2.19

Net Cash Inflow / Outflow

1.31

0.04

-0.80

0.86

2.13

10.76

5.34

3.48

2.42

1.92

Opening Cash & Equivalents

1.23

1.18

1.99

1.13

27.51

16.75

11.41

7.93

5.51

3.59

Closing Cash & Equivalent

2.53

1.23

1.18

1.99

29.64

27.51

16.75

11.41

7.93

5.51

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 174.32 168.79 133.48 117.09 86.44 71.92 58.73 48.72 40.23 31.31 ROA 14.37% 21.99% 22.36% 20.10% 18.13% 18.40% 16.15% 13.92% 15.74% 19.26% ROE 18.89% 28.54% 29.75% 28.55% 29.28% 31.77% 30.05% 30.06% 36.05% 48.33% ROCE 25.73% 36.90% 41.99% 39.26% 40.17% 42.35% 40.94% 40.35% 48.37% 60.35% Fixed Asset Turnover 4.09 4.66 4.50 4.11 3.87 3.63 3.25 3.20 3.22 3.80 Receivable days 62.51 52.73 34.30 25.83 25.28 27.12 27.12 25.04 25.25 27.26 Inventory Days 31.82 24.75 27.85 33.02 30.41 29.70 33.53 36.11 36.12 35.63 Payable days 23.07 21.37 23.54 22.02 18.13 22.50 22.27 17.49 26.11 41.49 Cash Conversion Cycle 71.26 56.11 38.61 36.83 37.56 34.32 38.37 43.66 35.26 21.41 Total Debt/Equity 0.04 0.10 0.00 0.12 0.13 0.20 0.07 0.20 0.13 0.15 Interest Cover 41.22 70.02 62.32 50.96 45.51 41.21 9.17 10.41 14.57 17.62

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

174.32

168.79

133.48

117.09

86.44

71.92

58.73

48.72

40.23

31.31

ROA

14.37%

21.99%

22.36%

20.10%

18.13%

18.40%

16.15%

13.92%

15.74%

19.26%

ROE

18.89%

28.54%

29.75%

28.55%

29.28%

31.77%

30.05%

30.06%

36.05%

48.33%

ROCE

25.73%

36.90%

41.99%

39.26%

40.17%

42.35%

40.94%

40.35%

48.37%

60.35%

Fixed Asset Turnover

4.09

4.66

4.50

4.11

3.87

3.63

3.25

3.20

3.22

3.80

Receivable days

62.51

52.73

34.30

25.83

25.28

27.12

25.04

25.25

27.26

Inventory Days

31.82

24.75

27.85

33.02

30.41

29.70

33.53

36.11

36.12

35.63

Payable days

23.07

21.37

23.54

22.02

18.13

22.50

22.27

17.49

26.11

41.49

Cash Conversion Cycle

71.26

56.11

38.61

36.83

37.56

34.32

38.37

43.66

35.26

21.41

Total Debt/Equity

0.04

0.10

0.00

0.12

0.13

0.20

0.07

0.20

0.13

0.15

Interest Cover

41.22

70.02

62.32

50.96

45.51

41.21

9.17

10.41

14.57

17.62

Jenburkt Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524731 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Jenburkt Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524731 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update